Dear All,
JPADR is going to release its new issue on December 01, 2022.
The APC has been waived for manuscript processing. Authors can submit their manuscripts for publication with zero processing fees for the upcoming issue (Volume 3 Issue 4).
Thank you
Read more about Volume 3 Issue 4
Volume 3 Issue 3 Published on September 01, 2022.
Number of articles -8
The Journal of Pharmacovigilance and Drug Research (JPADR) is the official publication of the Global Pharmacovigilance Society. This is an international, open access, and peer-reviewed scientific journal. It focuses on pharmacovigilance studies and their associated topics such as adverse drug reaction, drug clinical trials, drug effectiveness and efficacy, drugs risk management, as well as all aspects related to the safe use of drugs.
The JPADR is oriented to researchers, professors, students, and practitioners from both the pharmaceutical industry sector, as well as the wide range of health and medicine arenas. The journal’s objective is to establish a formal platform for communicating the research results on pharmacovigilance.
An official publication of Global Pharmacovigilance Society
“A goal towards patient safety and drug safety”
Abstracting and Indexing: National Digital Library of India, Google Scholar, Geneva foundation for medical education and research, J-Gate, ResearchBib, EuroPub, Zenodo, OpenAIRE, and more.
Contact: editor@jpadr.com/ editor.jpadr@gmail.com
Editor-in-Chief: Dr.Chinmaya Mahapatra, M.Pharm, Ph D.
ISSN (online) : 2582-7235
